News Rand Paul misses deadline by 16 months to report wife’s COVID-19 treatment stock purchase August 12, 2021 Morgan Watkins, Louisville Courier Journal Comments Off on Rand Paul misses deadline by 16 months to report wife’s COVID-19 treatment stock purchase Gilead Sciences produces remdesivir, an antiviral drug that has been used to treat COVID-19. Kelley Paul invested in Gilead Sciences on Feb. 26, 2020.